THCT · As filed with the SEC
THC Therapeutics balance sheet, by quarter
The statement as THC Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD
| USD | Q4 FY24 Jul 31, 2024 | Q3 FY24 Apr 30, 2024 | Q2 FY24 Jan 31, 2024 | Q1 FY24 Oct 31, 2023 | Q4 FY23 Jul 31, 2023 | Q3 FY23 Apr 30, 2023 | Q2 FY23 Jan 31, 2023 | Q1 FY23 Oct 31, 2022 |
|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||
| Cash and cash equivalents | — | 849 | 3,511 | 10 | 10 | — | — | — |
| Cash | 35 | — | — | — | — | 15 | 8,835 | 3,561 |
| Prepaid Expenses | 0 | 0 | 0 | 0 | 970 | 970 | 1,494 | 39,005 |
| Other Non-Operating Current Assets | — | — | — | — | — | — | — | 995 |
| Inventory | — | — | — | 0 | 0 | 0 | 0 | — |
| Total current assets | 35 | 849 | 3,511 | 10 | 980 | 985 | 10,329 | 43,561 |
| Physical silver assets | — | — | — | — | — | 0 | 0 | 0 |
| Property, Plant and Equipment | — | — | — | — | — | — | — | 0 |
| Physical silver assets | — | — | — | — | 0 | — | — | — |
| Intangible Assets | — | — | 11,308 | 11,659 | 12,010 | 12,361 | 12,701 | 13,052 |
| Intangible Assets | 10,613 | 10,964 | — | — | — | — | — | — |
| Total assets | 10,648 | 11,813 | 14,819 | 11,669 | 12,990 | 13,346 | 23,030 | 56,613 |
| Current liabilities | ||||||||
| Accounts Payable | 1,319,294 | 2,105,922 | 2,067,293 | 2,008,793 | 1,936,637 | 1,863,069 | 1,789,677 | 1,663,470 |
| Accounts Payable | — | — | — | — | — | — | — | 2,446 |
| Accrued expenses - related party | — | — | — | — | 5,180 | — | — | — |
| Accrued expenses - related party | — | 6,874 | 6,874 | 6,032 | — | 4,330 | 3,515 | — |
| Accounts payable and accrued liabilities - related party | 1,001,001 | — | — | — | — | — | — | — |
| Advances from related parties | 145,106 | 145,106 | 59,626 | 59,917 | 59,648 | 59,606 | 66,248 | 99,252 |
| Long-Term Debt | — | — | — | — | 25,000 | — | — | — |
| Short-Term Debt | — | — | — | — | 576,028 | — | — | — |
| Short-Term Debt | 25,000 | 25,000 | 25,000 | 25,000 | — | 25,000 | 25,000 | 25,000 |
| Short-Term Debt | 576,028 | 576,028 | 576,028 | 576,028 | — | 576,028 | 576,028 | 576,028 |
| Convertible notes payable- related party | — | 130,761 | 130,761 | 130,761 | — | 130,761 | 130,761 | 130,761 |
| Convertible notes payable, related party | 130,761 | — | — | — | 130,761 | — | — | — |
| Other Non-Operating Current Liabilities | 615,013 | 441,953 | 944,610 | 477,456 | 489,569 | 531,444 | 703,048 | 2,682,645 |
| Total current liabilities | 3,812,203 | 3,431,644 | 3,810,192 | 3,283,987 | 3,222,823 | 3,190,238 | 3,294,277 | 5,179,602 |
| Total liabilities | 3,812,203 | 3,431,644 | 3,810,192 | 3,283,987 | 3,222,823 | 3,190,238 | 3,294,277 | 5,179,602 |
| Commitments and Contingencies (See note 10) | 0 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| Stockholders' deficit | ||||||||
| Preferred Stock | — | — | — | — | — | — | 0 | 0 |
| Series A Preferred Stock. | — | — | — | — | 226 | — | — | — |
| Series A Preferred Stock | 826 | 826 | 226 | 226 | — | 226 | 226 | 226 |
| Series B Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Series C Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 40,266 | 40,266 | 32,746 | 32,746 | 32,746 | 32,746 | 32,746 | 32,746 |
| Treasury stock, at cost, 1,400,0000 shares as of April 30, 2024 and July 31, 2023, respectively. | — | (97,500) | — | — | — | — | — | — |
| Stock payable | — | 486,228 | 752,228 | 752,228 | 752,228 | 752,228 | 752,228 | 622,278 |
| Stock receivable | — | — | — | — | — | (6,902,000) | (6,902,000) | (6,902,000) |
| Stock receivable | — | (6,902,000) | (6,902,000) | (6,902,000) | (6,902,000) | — | — | — |
| Treasury stock | (97,500) | — | — | — | — | — | — | — |
| Stock payable | 486,228 | — | — | — | — | — | — | — |
| Stock receivable | (6,902,000) | — | — | — | — | — | — | — |
| Additional Paid-In Capital | 41,906,132 | 41,906,132 | 41,279,832 | 41,230,912 | 41,230,912 | 41,230,912 | 41,230,912 | 41,194,972 |
| Retained Earnings | (39,235,507) | (38,953,783) | (39,058,405) | (38,486,430) | (38,423,945) | (38,391,004) | (38,485,359) | (40,171,211) |
| Total stockholders' deficit | (3,801,555) | (3,519,831) | (3,895,373) | (3,372,318) | (3,309,833) | (3,276,892) | (3,371,247) | (5,222,989) |
| Total liabilities and stockholders' deficit | 10,648 | 11,813 | 14,819 | 11,669 | 12,990 | 13,346 | 23,030 | 56,613 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.